TECELRA

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

TECELRA

Nov 5, 2024, 17:16 | Insight

Shahrin Ahmed: Advanced Synovial Sarcoma has been approved by the FDA as an engineered cell therapy

Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: "Advanced…

Aug 6, 2024, 11:47 | Drugs

FDA Grants Accelerated Approval to Afamitresgene Autoleucel (TECELRA) for Treating Advanced Synovial Sarcoma

On August 2, 2024, the FDA made history by granting accelerated approval to afamitresgene autoleucel…

Aug 4, 2024, 18:55 | Drugs

Amol Akhade: First T cell therapy for metastatic synovial sarcoma

Amol Akhade shared a post on X: "FDA approves first T cell therapy for metastatic…

Aug 4, 2024, 10:24 | Blog

Sonia Guedan: TECELRA to become the first engineered cell therapy for a solid tumor cancer

Sonia Guedan, Cancer Immunologist at Hospital Clinic Barcelona, shared a post on X: "TECELRA (afamitresgene autoleucel) has…

All: 4 Posts: 1 - 100

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023